Skip to main content
OpenTrials
Completed

NCT Number: NCT01034436

Fatty Acid Quality and Overweight (FO-study)

The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Akershus University College

Oslo, Lillestrom, 2001, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • no use of medication, healthy, 27<BMI<40

Exclusion criteria

  • pregnant and lactating women, chronic diseases.

Treatment and study plan

fatty acid quality and overweight

Dietary Supplement

Duration 12 weeks

Primary outcomes

  1. Will intake of fat as diacylglycerols give weight reduction in overweight individuals?

    Time frame: baseline (0 weeks), 12 weeks

Secondary outcomes

  1. Will a high intake of ALA involve reduced levels of inflammatory markers?

    Time frame: baseline (0 weeks), 12 weeks

  2. Will a high intake of ALA involve changes in insulin sensitivity?

    Time frame: baseline (0 weeks), 12 weeks

Sponsors and collaborators

Lead sponsor

Oslo Metropolitan University

Other

Registry information

Official study title

Fatty Acid Quality and Overweight

Important dates

Study start
2009
Primary completion
2009
First posted
Dec 17, 2009
Registry last updated
Jun 18, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.